论文部分内容阅读
目的研究老年骨质疏松患者采用基础治疗并加用鲑鱼降钙素的临床疗效。方法选取2015年10月-2016年10月湖北医药学院附属人民医院收治的骨质疏松老年患者68例为研究对象,将其随机分为对照组和研究组各34例,两组患者均给予基础治疗,研究组加服鲑鱼降钙素,观察两组疗效。结果治疗后,研究组总有效率为88.2%,明显高于对照组的73.5%,差异有统计学意义(P<0.05)。研究组治疗后BMD较治疗前明显增加,差异有统计学意义(P<0.05);对照组治疗后BMD较治疗前比较,差异无统计学意义(P>0.05)。结论采用鲑鱼降钙素能明显提高老年骨质疏松患者的骨密度,缓解患者疼痛症状,疗效确切,值得推广。
Objective To study the clinical efficacy of basic treatment and salmon calcitonin in senile patients with osteoporosis. Methods Sixty-eight elderly patients with osteoporosis were selected from the People’s Hospital of Hubei Medical College from October 2015 to October 2016. The subjects were randomly divided into control group and study group of 34 cases, both groups were given basic Treatment, the study group served salmon calcitonin, two groups were observed. Results After treatment, the total effective rate of the study group was 88.2%, which was significantly higher than that of the control group (73.5%), the difference was statistically significant (P <0.05). The BMD of study group after treatment was significantly higher than that before treatment, the difference was statistically significant (P <0.05). The BMD of the control group after treatment was not statistically significant (P> 0.05). Conclusion The use of salmon calcitonin can significantly improve bone mineral density in elderly patients with osteoporosis, relieve pain symptoms in patients with curative effect, which is worthy of promotion.